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BACKGROUND: Over the past few years, advances in molecular technologies have allowed unprecedented mapping of epigenetic modi-
ﬁcations in gametes and during early embryonic development. This work is allowing a detailed genomic analysis, which for the ﬁrst time
can answer long-standing questions about epigenetic regulation and reprogramming, and highlights differences between mouse and human,
the implications of which are only beginning to be explored.
OBJECTIVE AND RATIONALE: In this review, we summarise new low-cell molecular methods enabling the interrogation of epigenetic
information in gametes and early embryos, the mechanistic insights these have provided, and contrast the ﬁndings in mouse and human.
SEARCH METHODS: Relevant studies were identiﬁed by PubMed search.
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OUTCOMES: We discuss the levels of epigenetic regulation, from DNA modiﬁcations to chromatin organisation, during mouse gametogenesis,
fertilisation and pre- and post-implantation development. The recently characterised features of the oocyte epigenome highlight its exceptionally
unique regulatory landscape. The chromatin organisation and epigenetic landscape of both gametic genomes are rapidly reprogrammed after fer-
tilisation. This extensive epigenetic remodelling is necessary for zygotic genome activation, but the mechanistic link remains unclear. While the
vast majority of epigenetic information from the gametes is erased in pre-implantation development, new insights suggest that repressive histone
modiﬁcations from the oocyte may mediate a novel mechanism of imprinting. To date, the characterisation of epigenetics in human development
has been almost exclusively limited to DNA methylation proﬁling; these data reinforce that the global dynamics are conserved between mouse
and human. However, as we look closer, it is becoming apparent that the mechanisms regulating these dynamics are distinct. These early ﬁndings
emphasise the importance of investigations of fundamental epigenetic mechanisms in both mouse and humans.
WIDER IMPLICATIONS: Failures in epigenetic regulation have been implicated in human disease and infertility. With increasing mater-
nal age and use of reproductive technologies in countries all over the world, it is becoming ever more important to understand the neces-
sary processes required to establish a developmentally competent embryo. Furthermore, it is essential to evaluate the extent to which
these epigenetic patterns are sensitive to such technologies and other adverse environmental exposures.
Key words: DNA methylation / imprinting / development / epigenetics / oocyte / embryo / sperm / chromatin / histones
Introduction
All cell types of an organism contain identical genetic information and
yet are distinct in function and characteristics. Instructive epigenetic
marks are key to this developmental conundrum. Epigenetic marks
include modiﬁcations to the DNA or its associated proteins, which
enable regulation of gene expression in a cell type-speciﬁc manner
(Fig. 1). Among the most well-characterised epigenetic modiﬁcations
is DNA methylation, but the various additional layers of epigenetic
information may represent more dynamic and responsive features of
this regulation landscape. DNA is wrapped around an octamer of his-
tone proteins (a nucleosome) enabling its compaction and organisa-
tion in the nucleus. Numerous post-translational modiﬁcations and/
or variants of these histone proteins can facilitate the packaging of
chromatin into accessible or inaccessible states and, consequently,
regions of active or repressed gene expression, respectively.
The ﬁeld of developmental biology has long studied the intriguing
nature of how two fully differentiated and very distinct cells, the sperm
and the oocyte, can come together to create a totipotent embryo.
Genetic studies in mice have ﬁrmly established that epigenetic regula-
tion is key to the acquisition of totipotency during this transition. Early
studies using molecular approaches and immunoﬂuorescence showed
that widespread epigenetic reprogramming accompanies both germ
cell and embryonic development (Santos et al., 2002; Seisenberger
et al., 2012). However, limitations in obtaining large numbers of cells,
speciﬁcally in oogenesis and early embryogenesis, has restricted the
detailed molecular investigation in these cells, until recently. Advances
in low-input and single-cell sequencing methods have not only
improved our understanding of these developmental windows, but the
data have also led to new questions and challenged existing dogmas/
hypotheses. In this review, we summarise the current knowledge of
epigenetic dynamics in development, from DNA methylation to
chromosome organisation, speciﬁcally during spermatogenesis, oogen-
esis, pre-implantation development and early lineage speciﬁcation. We
will discuss how the mechanistic insights established in mice may be
relevant for human development and reﬂect on known differences
between the two systems. In this review, we focus particularly on the
recent developments in in-vivo studies.
Recent advances in epigenetic
proﬁling technologies
Next generation sequencing based approaches have revolutionised
our ability to proﬁle epigenetic information and all layers of the epi-
genome can now be interrogated by these methods. Until relatively
recently, these technologies have required millions of cells to obtain
high resolution genomic maps, but advances in capturing and amplify-
ing smaller and smaller amounts of material have allowed them to be
scaled down to require only minimal numbers of cells (Table I).
DNA methylation can be studied with greatest resolution and pre-
cision by bisulphite conversion followed by sequencing (Cokus et al.,
2008). Bisulphite treatment converts the DNA base cytosine to
uracil, but only when the cytosine is unmethylated. In this manner,
methylated and unmethylated cytosines can be distinguished by
sequencing. Bisulphite sequencing initially required large amounts of
starting material because the bisulphite conversion reaction leads to
DNA breaks and loss of material. This problem has been overcome
by reﬁnements in methods such as post bisulphite-adaptor tagging
(PBAT) and reduced representation bisulphite (RRBS) sequencing,
which allow the interrogation of DNA methylation in just 100–200
cells or even on a single-cell level (Miura et al., 2012; Smallwood and
Kelsey, 2012; Guo et al., 2013; Smallwood et al., 2014). Methods
independent of bisulphite chemistry may provide alternatives that cir-
cumvent the loss of material inherent in bisulphite treatment (Boers
et al., 2018). A variety of approaches have also been developed to
map oxidation derivatives of 5-methylcytosine, some at the single-cell
level, but they typically lack the sensitivity or absolute quantiﬁcation
of bisulphite sequencing (Kelsey et al., 2017).
Histone proteins can be post-translationally modiﬁed at numerous
amino acid residues in the protruding N-terminal tail or core domain
(Zhao and Garcia, 2015); these predominantly include methylation,
acetylation, phosphorylation and ubiquitination. Using antibodies, the
abundance and nuclear distribution of these modiﬁcation states have
been studied by immunoﬂuorescence and Western blots. Determining
their genomic occupancy depends upon using antibodies to precipitate
chromatin fragments (chromatin immunoprecipitation, ChIP) followed
by puriﬁcation of the associated DNA. In 2006, next-generation
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Figure 1 Levels of epigenetic regulation. The DNA sequence can be methylated at cytosine residues in a CpG context, termed DNA methylation.
DNA is wrapped around the histone octamer to form the nucleosome. Variants and post-translational modiﬁcations of these histone proteins form
another layer of epigenetic regulation. The state of these epigenetic modiﬁcations together determines whether the chromatin will be organised in
an accessible ‘open’ or an inaccessible ‘closed’ state. Higher order folds and loops organise the chromatin into active and inactive compartments.
.............................................................................................................................................................................................
Table I Low-input and single cell methods available for assaying epigenetic modiﬁcations.
Epigenetic layer Assay Low-cell protocol Single-cell protocol
DNA methylation Post-bisulﬁte adaptor tagging
(PBAT)
400 cells (Miura et al., 2012) Yes (Smallwood et al., 2014)
Reduced representation bisulﬁte
sequencing (RRBS)
75–1000 cells (Smallwood and Kelsey, 2012) Yes (Guo et al., 2013)
Histone modiﬁcations Chromatin immunoprecipitation
(ChIP)-seq
400–1000 cells (Brind’Amour et al, 2015, Zhang et al.,
2016, Dahl et al., 2016, Hanna et al., 2018)
Yes* (Rotem et al., 2015)
Cleavage under targets and release
using nuclease (CUT&RUN)
100 cells (Skene et al., 2018) Not available
Chromatin accessibility Assay for transposase accessible
chromatin (ATAC)-seq
20–100 cells (Wu et al., 2016, Wu et al., 2018) Yes (Buenrostro et al., 2015;
Cusanovich et al., 2015)
DNase-seq 100–200 cells (Lu et al., 2016) Yes (Jin et al., 2015)
DNA methylation and
chromatin accessibility
Nucleosome occupancy and
methylome (NOMe)-seq
Not available Yes (Pott, 2017, Guo et al.,
2017a, Clark et al., 2018)
Higher order organisation Hi-C 500 cells (Du et al., 2017) Yes (Nagano et al., 2013)
*Only applied using thousands of cells.
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sequencing was applied for the ﬁrst time to obtain genome-wide maps
of histone modiﬁcations, in a method termed ChIP-seq (Barski et al.,
2007; Mikkelsen et al., 2007; Robertson et al., 2007). This method is
an enrichment-based approach that is strongly dependent on antibody
efﬁciency and speciﬁcity. Only recently, ChIP-seq has been adapted for
low-cell inputs of 500–1000 cells (Brind’Amour et al., 2015; Dahl et al.,
2016; Zhang et al., 2016; Hanna et al., 2018), and single-cell
approaches still require the processing of thousands of individual cells
(Rotem et al., 2015). A novel approach, termed cleavage under targets
and release using nuclease (CUT&RUN), has been developed to allow
the evaluation of histone modiﬁcation patterns in as few as 100 cells
(Skene et al., 2018). CUT&RUN involves tethering a DNA-cutting
enzyme to a histone-bound antibody, resulting in only targeted DNA-
wrapped nucleosomes being released into solution for sequencing
(Skene et al., 2018).
Chromatin states can be analysed further by a variety of methods
that use enzymes to isolate accessible from inaccessible regions of
DNA. For example, the assay of transposase-accessible chromatin
(ATAC-seq) employs the Tn5 transposase to integrate sequencing
adapters into regions of accessible chromatin (Buenrostro et al.,
2013), while DNase-seq employs the DNase I enzyme to cleave
these regions (Boyle et al., 2008). Both methods have recently been
adapted for single-cell and low-cell input (Buenrostro et al., 2015;
Cusanovich et al., 2015; Jin et al., 2015; Lu et al., 2016; Wu et al.,
2016). An alternative assay, termed nucleosome occupancy and
methylome (NOMe-seq), uses a unique non-enrichment-based
approach to evaluate chromatin accessibility, by exploiting a bacterial
methyltransferase (Kelly et al., 2012). Accessible regions of DNA are
demarked with GpC methylation, and therefore subsequent bisul-
phite sequencing not only provides information on DNA accessibility
but additionally endogenous DNA methylation patterns. NOMe-seq
has been successfully adapted to the single-cell level (Pott, 2017; Guo
et al., 2017a; Clark et al., 2018).
On a larger scale, chromatin conformation capture (Hi-C) methods
evaluate chromosome interactions from a deﬁned loci or throughout
the nucleus, using cross-linking to ligate regions of DNA that lie in close
proximity to each other (Lieberman-Aiden et al., 2009). The so-called
topological associated domains (TADs) partition the genome into large
self-interacting A (active) and B (silent) compartments. Hi-C sequencing
can also be conducted on a single-cell level (Nagano et al., 2013), but at
rather limited resolution. At higher resolution, HiC-based methods can
identify enhancer-promoter interactions, but this application is not yet
possible in low numbers of cells.
Epigenetic regulation of gene
expression
In differentiated cells, there are canonical patterns of epigenetic
marks across genomic elements (Fig. 2). DNA methylation is gener-
ally high across gene bodies and inter-genic regions, with low or inter-
mediate methylation observed almost exclusively at regulatory
regions, such as promoters and enhancers. Histone marks, typiﬁed by
histone H3 modiﬁcations, also show reproducible genomic patterns,
some of which are correlated with gene expression. Active marks,
such as histone 3 lysine 4 trimethylation (H3K4me3) and/or histone
3 lysine 27 acetylation (H3K27ac), are found at active promoters
and/or enhancers, are negatively correlated with DNA methylation,
and positively correlated with gene expression (Fig. 2) (Smith and
Meissner, 2013). Repressive histone marks, such as H3K36me3 across
transcribed gene bodies and H3K9me2 and/or H3K9me3, are strongly
associated with DNA methylation and transcriptional silencing (Du et al.,
2015). While gene body H3K36me3 is positively correlated with tran-
scription, paradoxically it is thought to function across gene bodies by
repressing spurious, off-target transcription initiation (Neri et al., 2017)
and promoting acquisition of DNA methylation (Baubec et al., 2015).
Alternatively, while repressive H3K27me3 is associated with transcrip-
tional silencing, it is predominantly localised with unmethylated DNA,
suggesting it may be complementary mode of genomic silencing (Fig. 2)
(Manzo et al., 2017). While many other modiﬁcations of histone pro-
teins have been reported (Zhao and Garcia, 2015), in this review we
focus on the aforementioned well-characterised histone modiﬁcations.
DNA methylation is established and maintained by a protein family
of ﬁve DNA methyltransferases (DNMTs). Among these, three de-
novo DNMTs (DNMT3A, 3B and 3C) and a catalytically inactive co-
factor (DNMT3L) are responsible for establishing cytosine methyla-
tion, usually in a CpG context (Okano et al., 1999; Bourc’his et al.,
2001; Barau et al., 2016). It is not fully apparent how DNA methyla-
tion is targeted to speciﬁc regions of the genome, but biochemical
studies have shown that several domains on the DNMT proteins or
their co-factors can interact with modiﬁed histone tails (Ooi et al.,
2007; Dhayalan et al., 2010). During cell replication, DNMT1 is loca-
lised to hemi-methylated DNA at the replication fork by the co-
factor UHRF1 (Bostick et al., 2007; Sharif et al., 2007), where it faith-
fully copies CpG methylation patterns to the newly replicated DNA
strand (Li et al., 1992). Once established, DNA methylation can be
repressive for transcription either by impairing the binding of tran-
scription factors or through the activity of methyl-binding proteins
(Hendrich and Bird, 1998; Domcke et al., 2015). Classic examples of the
repressive role for DNA methylation are X-chromosome inactivation in
females and imprinted gene regulation, where one parental allele is
silenced through the inheritance of differential germline methylation
(Jones, 2012). Methylated cytosine can be oxidised to the derivatives 5-
hydroxymethylcytosine, 5-formylcytosine and 5-carboxylcytosine through
the action of Ten-Eleven Translocation (TET) proteins, but whether
these derivatives function as epigenetic marks in a manner similar to 5-
methylcytosine is not clear (Wu and Zhang, 2017).
The modiﬁcations of histone tails are dynamically regulated by so-
called ‘writers’ and ‘erasers’, and once established can be bound by
‘readers’ (Cheng, 2014; Rothbart and Strahl, 2014; Torres and Fujimori,
2015; Allis and Jenuwein, 2016). There is an ever-growing list of proteins
that can modulate and/or bind histones (http://weram.biocuckoo.org/
), suggesting that the complexity of this system is extensive. In general
terms, active and repressive histone marks, through their respective
readers, can enable the immediately surrounding chromatin to be pack-
aged in an open (accessible) or closed (inaccessible) conformation,
respectively (Zhang et al., 2015). Regions of open or closed chromatin
are organised into self-interacting compartments, termed TADs, which
are on average ~1Mb in size (Dixon et al., 2012). Within the nucleus,
TADs of similar chromatin conformation are more likely to organise
together into active and inactive (A and B) compartments (Lieberman-
Aiden et al., 2009). This supports the notion that there is coordinate
regulation of transcriptional activity through the 3D organisation of DNA
within the nucleus.
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Ongoing work in model systems including, but not limited to, the
mouse is building our understanding of the interplay between these
epigenetic layers and how they coordinate genomic regulation. One
way to evaluate these relationships is to study their dynamics during
developmental reprogramming and lineage speciﬁcation, an area of
research that has rapidly advanced in the past few years.
Mechanistic insights from mouse
models
Gametogenesis
The chromatin organisation and epigenetic proﬁles of the male and
female gametes at the time of fertilisation are profoundly different.
Sperm DNA is highly methylated and tightly packaged with prota-
mines, a protein that replaces canonical histones (Wright, 1999);
while oocyte DNA is uniquely methylated in an bimodal pattern and
is associated with non-canonical distributions of histone modiﬁcations
(Tomizawa et al., 2012) (Fig. 3). These divergent patterns are estab-
lished during gametogenesis, which is initiated during embryonic
development. The precursors for both male and female germ cells
are assigned in the epiblast at embryonic day (E) 7.25 and as these
primordial germ cells (PGCs) migrate to the genital ridge (E9.5–
E11.5), they undergo almost complete demethylation of the genomic
DNA (Guibert et al., 2012; Seisenberger et al., 2012). The loss of
DNA methylation is due to downregulation of both de-novo DNMTs
and the DNMT1-cofactor UHRF1 (Kagiwada et al., 2013). With the
decline of DNA methylation, there is a re-organisation of repressive
histone marks as well, with widespread loss of H3K9me2 and an
Figure 2 Canonical epigenetic patterns. H3K4me3 is associated with actively transcribed promoters, as well as CpG islands, irrespective of tran-
scription. H3K27ac demarks active promoters and enhancers, while associated transcribed genes bodies are enriched for H3K36me3. Repressed
regions of the genome are typically associated with either H3K9me2/3 or H3K27me3. DNA is generally highly methylated throughout the genome,
with the exception of regulatory regions marked by H3K4me3 and/or H3K27ac, and H3K27me3- domains. Methylated CpGs are depicted as closed
circles and unmethylated CpGs are open circles.
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Figure 3 Epigenetic reprogramming in mouse development. (A) Epigenetic patterns are shown for non-growing oocytes and fully grown germinal ves-
icle (GV) oocytes. In non-growing oocytes, DNA is almost completely unmethylated, H3K4me3 is exclusively enriched at active promoters and
H3K27me3 is spanning broad non-canonical domains. By the fully grown GV stage, DNA across transcribed gene bodies is fully methylated and
H3K4me3 has accumulated in broad domains throughout untranscribed regions. (B) Schematic of epigenetic reprogramming events during gametogenesis
and embryogenesis. DNA methylation is erased in primordial germ cells and re-established earlier in the sperm of males and after birth in oocytes in
females. Oocytes acquire lower overall methylation than sperm, with non-canonical genome-wide distribution. After fertilisation, the paternal DNA is
rapidly demethylated, while maternal DNA methylation is passively lost over several cell divisions. DNA methylation is re-acquired in canonical patterns
in the post-implantation embryo, concomitant with lineage speciﬁcation. H3K4me3 is non-canonically distributed in the oocyte, is rapidly erased after fer-
tilisation, and becomes canonically enriched at CpG islands and active promoters. Very few domains retain H3K4me3-marked histones in the protamine
exchange in sperm and subsequently through the re-acquisition of histones in the zygote. H3K27me3 acquires a non-canonically broad distribution in
PGCs in the absence of other repressive epigenetic marks. This pattern is relatively maintained throughout oogenesis, while very few H3K27me3-marked
histones are retained in the sperm protamine exchange. In the pre-implantation embryo, H3K27me3-transmitted from the gametes is progressively lost,
with pronounced loss at CpG-rich regions. H3K27me3 is then re-established in a canonical pattern in the post-implantation embryo. Chromatin accessib-
ility is contrastingly and exceptionally open in the oocyte and compact in the sperm. The open chromatin state of maternal DNA is gradually resolved in
the pre-implantation embryo, while the compact packaging of paternal DNA is rapidly resolved with incorporation of histones in the zygote. Topological
associated domains (TADs) are nearly absent in the mature oocyte and become gradually re-instated in the pre-implantation embryo.
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increase of H3K27me3 (Seki et al., 2005). PGCs then subsequently
progress either into spermatogenesis or oogenesis, depending on the
sex of the embryo.
In early sperm progenitors (prospermatogonia), DNA methylation
begins to be re-established before birth (E15.5–E18.5) and is com-
pleted at the termination of meiotic pachytene after birth (D10–19)
(Hajkova et al., 2002) (Fig. 3). DNA methylation is essential for mei-
otic progression (Bourc’his and Bestor, 2004). Methylation of sperm
DNA broadly resembles other cell types in that it is almost uniformly
methylated with the exception of regulatory regions. While the DNA
is initially wrapped around histones in spermatocytes, the vast major-
ity of histones are replaced, ﬁrst with non-canonical histone variants
and transition proteins, which are subsequently replaced with prota-
mines during maturation, allowing the DNA to be tightly packaged
into the compact sperm head (Balhorn et al., 2000; Bao and Bedford,
2016). The functional relevance of the ~1% of histones that are
retained in mature sperm is still debated. It seems that at least a sub-
set of these histones reside at CpG-rich promoters with low DNA
methylation, although it has been suggested that the vast majority are
retained in gene poor regions (Erkek et al., 2013; Carone et al.,
2014). Residual histones in sperm support the possibility of interge-
nerational or possibly transgenerational inheritance of an intrinsic epi-
genetic memory programme through the male germline. Indeed, loss
of H3K4me2 in sperm caused by forced expression of an H3K4-
demethylase has been shown to impair the viability of offspring in
subsequent generations (Siklenka et al., 2015).
Shortly after the migration of germ cells to the gonad in females,
there is massive mitotic expansion of this germ cell pool (E11.5). At
E13.5, these oocyte precursors enter meiotic arrest in prophase I
and remain quiescent in the developing ovary until after birth when
they are assembled into primordial follicles. These cells represent the
oocyte pool for the female’s entire lifespan, only a small subset of
which will ever become fully mature and ovulate, as the vast majority
will undergo apoptosis.
During folliculogenesis, oocytes undergo de-novo DNA methylation
in the phase of oocyte growth (Hiura et al., 2006), mediated by the
de-novo DNA methyltransferases DNMT3A and cofactor DNMT3L
(Bourc’his et al., 2001; Kaneda et al., 2004) (Fig. 3). Unlike the highly
methylated sperm, oocyte methylation is distinctly located over tran-
scribed gene bodies (Kobayashi et al., 2012; Veselovska et al., 2015)
in a pattern that is unique among mammalian cell types. The acquisi-
tion of DNA methylation across transcribed regions has been sug-
gested to be dependent on the modiﬁcation of associated histones,
including acquisition of H3K36me3 and exclusion of H3K4me3 by
H3K4 demethylases KDM1A/B (Stewart et al., 2015; Gahurova et al.,
2017). DNMT1 and UHRF1 are required to complete de-novo methy-
lation, which is unusual as this protein complex normally functions in
the context of maintenance methylation (Shirane et al., 2013;
Maenohara et al., 2017). Oocytes also have unusually high levels of
methylation of cytosines outside of a CpG context. The functional
signiﬁcance of this ‘non-CpG’ methylation is unclear and may merely
reﬂect the protracted period during which the de-novo methyltrans-
ferases are active (Tomizawa et al., 2012; Shirane et al., 2013).
Curiously, DNA methylation in general has no obvious function in
oocytes, as loss of DNA methylation through conditional deletion of
Dnmt3a or Dnmt3L has no effect on oogenesis (Kaneda et al., 2004;
Bourc’his et al., 2001).
Intriguingly, across the unmethylated fraction of the oocyte gen-
ome, histone modiﬁcation patterns are also non-canonical in their
distribution. A histone mark typically associated with active promo-
ters, H3K4me3, accumulates in a transcription-independent manner
at unusually broad, inter-genic domains (Dahl et al., 2016; Zhang
et al., 2016; Hanna et al., 2018) (Fig. 3). This non-canonical pattern of
H3K4me3 has been attributed to the activity of a single H3K4
methyltransferase, MLL2 and appears to be, at least partially, driven
by underlying CpG density (Hanna et al., 2018). Paradoxically, acqui-
sition of non-canonical domains of H3K4me3 appears to be required
for genome-wide transcriptional silencing associated with oocyte mat-
uration and resumption of meiosis (Andreu-Vieyra et al., 2010; Dahl
et al., 2016; Zhang et al., 2016). Repressive H3K27me3, is also found
broadly throughout unmethylated genomic regions and appears to be
actively excluded from transcribed regions throughout oogenesis
(Zheng et al., 2016) (Fig. 3). The role of H3K27me3 in oogenesis is
not clear, but it appears to be required to establish a non-canonical
form of imprinting in the early embryo (Inoue et al., 2017a), discussed
in more detail below.
The oocyte also has a very distinct chromosome architecture com-
pared to other cell types. Chromatin undergoes major conform-
ational changes during the ﬁnal stages of maturation in the germinal
vesicle (GV) oocyte, from a non-surrounded nucleolar-like body
(NSN) to a surrounded (SN) state (Mattson and Albertini, 1990;
Zuccotti et al., 1995) accompanying transcriptional silencing. In GV
oocytes, Hi-C studies have found chromosome interactions such as
TADs and chromosome loops, but the strength of these interactions
begin to decrease as the oocytes progress through the NSN to SN
transition (Flyamer et al., 2017). With resumption of meiosis, oocytes
appear to lose all higher-order chromatin structures, such that meta-
phase II (MII) oocytes show a uniform interaction pattern along entire
chromosomes that appears to be locus independent (Ke et al., 2017;
Du et al., 2017).
The distinct epigenetic patterns observed in the oocyte suggest
that there may be an uncoupling of some of the conventional
mechanisms of gene regulation. This uncoupling might be a require-
ment to allow the oocyte to maintain necessary gene regulation,
while simultaneously establishing an epigenome capable of facilitating
the early events of embryogenesis.
From germ cells to the embryo
In the zygote, the maternal and paternal genomic contributions are
reprogrammed distinctively and these dynamics are required for the
acquisition of totipotency and zygotic genome activation (ZGA).
Immediately after fertilisation, the paternal protamines are replaced
by maternal histones accompanied by widespread erasure of almost
all paternal DNA methylation. This was proposed to be active
demethylation mediated through TET activity (Gu et al., 2011; Inoue
and Zhang, 2011), but recent data challenges this ﬁnding (Amouroux
et al., 2016) and thus the mechanism of this initial erasure remains
unresolved (Hill et al., 2014). Conversely, maternal DNA methylation
is largely preserved at this stage. However, it does appear that the
widespread, non-canonical maternal H3K4me3 needs to be repro-
grammed in order for the embryo to initiate ZGA and this occurs
through activity of H3K4 demethylases KDM5B and KDM1A (Zhang
et al., 2016; Dahl et al., 2016; Ancelin et al., 2016).
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Long-range and local chromosome interactions are not immedi-
ately restored in the post-meiotic zygote, as is the case for mitotic
cells. Intriguingly, re-establishment of higher-order chromatin struc-
ture occurs independently of ZGA and cell cycle, suggesting that add-
itional factors are required for re-establishing these interactions (Du
et al., 2017). Chromosome compartmentalisation in zygotes is asso-
ciated with DNA methylation, chromatin accessibility and H3K27me3,
but not broad maternal H3K4me3 (Ke et al., 2017).
As the embryo develops towards the blastocyst stage, DNA
methylation is passively lost from both the maternal and paternal gen-
omes, resulting in the erasure of most gametic DNA methylation.
There are a few thousand domains that are protected from this eras-
ure; these include, but are not limited to, imprinted domains and
some classes of repetitive elements (Smallwood et al., 2011). Similar
to DNA methylation, repressive H3K27me3 also appears to be pro-
gressively lost during pre-implantation development, with maternal
H3K27me3 being preferentially retained at distal, inter-genic regions
(Zheng et al., 2016). The mechanism for preferential loss or retention
of maternal H3K27me3 at speciﬁc loci remains unclear. In Drosophila,
maternally inherited H3K27me3 regulates the activation of enhancers
in the early embryo (Zenk et al., 2017). Considering the correlation
between compartmentalisation, chromatin accessibility and H3K27me3
(Ke et al., 2017), loss of H3K27me3 may also be required for the
establishment of promoter–enhancer interactions in mammalian
pre-implantation development. H3K9 di- and tri-methylation are
repressive histone modiﬁcations that are tightly associated with
DNA methylation and are bound by heterochromatin protein 1
(HP1) (Bannister et al., 2001; Lachner et al., 2001); however, there
is currently no molecular data evaluating the dynamics of H3K9
methylation in oocytes or early embryogenesis. Immunoﬂuorescence
shows that H3K9me3, typically associated with silenced repetitive DNA,
is predominantly inherited at maternal peri-centromeres in the early
embryo (Puschendorf et al., 2008). As the paternal chromatin structure
is newly re-established with the re-integration of histones, the peri-
centromeres are ﬁrst silenced by H3K7me3 and by the 8-cell stage simi-
larly acquire H3K9me3 (Puschendorf et al., 2008). In addition to
these repetitive regions, H3K9me2 and H3K9me3 may be required
to maintain silencing and protect parental DNA methylation at
imprinted domains (Nakamura et al., 2007; Quenneville et al.,
2011), as discussed in more detail below. Future characterisation of
the genomic distribution of H3K9me2/3 will be essential to deter-
mine the role for these marks in early gene regulation and protec-
tion of germline DNA methylation.
In addition to DNA methylation and histone remodelling in pre-
implantation development, chromatin structure appears to be pro-
gressively re-organised. ATAC-seq (Wu et al., 2016) and Hi-C
experiments (Du et al., 2017; Flyamer et al., 2017; Ke et al., 2017)
showed that zygotes have a very relaxed chromatin state, which is
gradually resolved to a more canonical state by the blastocyst stage,
a ﬁnding that is consistent with previous microscopy-based observa-
tions (Ahmed et al., 2010; Burton and Torres-Padilla, 2014). With
the re-establishment of higher-order chromatin structure in the pre-
implantation embryo, interactions between promoters and enhancers
become deﬁned (Du et al., 2017; Ke et al., 2017) and the number of
DNase hypersensitivity sites increases (Lu et al., 2016).
Together, the epigenetic proﬁles explored to date in pre-
implantation embryos demonstrate that the chromatin regulatory
landscape is dynamic during the transition from a totipotent to a
pluripotent embryo with reﬁnement of chromatin compartments and
localisation of H3K4me3 to promoters. Paradoxically, this transition
is accompanied by almost widespread loss of repressive DNA methy-
lation and H3K27me3, suggesting that targeting of transcriptional
machinery in pre-implantation embryo is not facilitated by these pro-
tective repressive marks.
Lineage speciﬁcation in post-implantation
development
Once the embryo implants, there are widespread morphological
changes as cell lineages differentiate, accompanied by epigenetic pro-
gramming. The role of epigenetic regulation during this lineage speciﬁ-
cation is complex and still not fully understood. Many studies
investigating epigenetic mechanisms in lineage speciﬁcation thus far
have used transgenic mouse models to identify key regulators; in-vivo
data showing the localisation and dynamics of epigenetic modiﬁca-
tions remain scarce.
There is substantial evidence for a function for repressive chroma-
tin marks in reinforcing lineage speciﬁcation. During post-implantation
development, there is de-novo acquisition of repressive DNA methy-
lation (Okano et al., 1999), H3K9me2 (Zylicz et al., 2015) and
H3K27me3 (Zheng et al., 2016), all of which are essential for
appropriate lineage development. Genetic ablation in mice of the
H3K27 methyltransferase EZH2 (O’Carroll et al., 2001), H3K9
methyltransferase EHMT2 (also known as G9A) (Tachibana et al.,
2002, 2005) or de-novo DNA methyltransferase DNMT3B (Okano
et al., 1999) all lead to developmental abnormalities and lethality
in mid-gestation.
In the post-implantation embryo, repressive H3K27me3 is targeted
de novo to transcriptionally silent promoters, including CpG islands,
and gene bodies, by Polycomb repressive complex proteins (Liu
et al., 2016; Zheng et al., 2016) and is required to keep these genes
transcriptionally repressed at this stage (Yang et al., 2018). This pro-
gramming corresponds to a widespread switch from the maternally
inherited enrichment pattern at silent inter-genic B compartments in
the pre-implantation embryo to the regulatory domains of active A
compartments in the post-implantation embryo (Zheng et al., 2016;
Ke et al., 2017). At many regulatory domains, H3K27me3 can be
found together with H3K4me3 in a chromatin state referred to as
bivalent. Bivalent domains are enriched at unmethylated, but silent,
promoters of developmental genes in the post-implantation epiblast
and extra-embryonic ectoderm (Rugg-Gunn et al., 2010). Bivalent
chromatin is thought to poise these genes for rapid activation or
repression during lineage speciﬁcation in the developing embryo
(Bernstein et al., 2006). Indeed, it has been shown during migration
and development of neural crest cells that bivalent genes are embed-
ded in large repressive Polycomb domains in which they maintain
plasticity and chromatin accessibility in all subpopulations (Minoux
et al., 2017). Upon differentiation, decreasing H3K27me3 and
increasing H3K4me2 then leads to cell type-speciﬁc gene expression
(Minoux et al., 2017). While the genomic location and resolution of
bivalent domains has now been characterised in vivo (Minoux et al.,
2017; Zheng et al., 2016), paralleling the observations made in cul-
tured cells, it remains unclear how H3K27me3 is targeted in the
post-implantation embryo.
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Unlike the targeted gain of H3K27me3 in the post-implantation
embryo, DNA methylation is established across ~80% of the embryonic
genome. Yet despite its widespread occurrence, DNA methylation
does not appear to be necessary to direct the transcriptional pro-
gramme in early embryos, but rather to reinforce lineage decisions
(Zhang et al., 2018). As such, there are a few key domains that become
differentially methylated between the post-implantation embryonic and
extra-embryonic compartments to prevent aberrant trans-differentiation
(Ng et al., 2008; Zhang et al., 2018). Similarly, differential methylation
was observed at functionally relevant enhancer elements between gas-
trulating tissues, suggesting that this mechanism may also reinforce lin-
eage commitment within the embryo (Zhang et al., 2018).
Interestingly, despite dramatic acquisition of H3K9me2 in post-
implantation development, it is not required for the genome-wide
gain of DNA methylation, but rather appears to be important for a
small subset of CpG-rich domains (Auclair et al., 2016). As such,
deposition of H3K9me2 is only necessary for efﬁcient repression of a
few germline-speciﬁc genes, mediated by silencing of their promoters
and/or enhancers (Zylicz et al., 2015; Auclair et al., 2016).
Furthermore, H3K9me2 deposited by EHMT2 is not required for
silencing the vast majority of repetitive elements (Zylicz et al., 2015).
Together these ﬁndings suggest that H3K9me2 is ubiquitously asso-
ciated with methylated DNA in the post-implantation embryo, but its
functional role is rather specialised. This may be attributable to
redundancies in repressive epigenetic marks or to these repressive
modiﬁcations acting not as upstream transcriptional regulators but
rather as reinforcements for transcriptionally inactive regions of
DNA.
Active chromatin marks, such as H3K4me3 and H3K27ac, also
likely play a role in transcriptional regulation during lineage speciﬁca-
tion. Active histone modiﬁcations can promote transcription by facili-
tating the accessibility of regulatory regions to transcription factors,
but whether these marks are required for establishing a transcrip-
tional programme or for merely reinforcing it remains contentious
(Howe et al., 2017). For example, the level of H3K4me3 at promo-
ters correlates with transcription and transcriptional machinery inter-
acts with H3K4me3; however, in many contexts, ablation of
H3K4me3 has a limited effect on transcription (Briggs et al., 2001;
Clouaire et al., 2012; Margaritis et al., 2012). The predominant H3K4
methyltransferase in the pre-implantation embryo is MLL2, while in
the post-implantation embryo it is SETD1A (Bledau et al., 2014).
However, due to the overlapping redundancy of the six H3K4
methyltransferase proteins, it has been challenging to interpret the
role for each methyltransferase and, in turn, H3K4me3 during
embryogenesis (Bledau et al., 2014). Embryos deﬁcient in H3K4
methyltransferases MLL1 and MLL2 both arrest in mid-gestation and
show patterning defects likely due to aberrant expression levels of a
subset of the Hox genes (Ernst et al., 2004; Glaser et al., 2006), sug-
gesting that MLL1/2-mediated H3K4me3 is required to express
appropriate levels of these genes. The post-implantation upregula-
tion of SETD1A appears to have a central role in lineage speciﬁca-
tion, as it is required to complete gastrulation (Bledau et al., 2014),
suggesting that it may be important for establishing transcriptional
patterning.
During differentiation, acquisition of H3K27ac at enhancers is asso-
ciated with the formation of enhancer-promoter interactions and
induction of their target genes (Wang et al., 2016; Rubin et al., 2017).
Knockout in mice of the H3K27 acetyltransferases CBP or p300
(which also acetylate other histone residues and interact with many
transcription factors themselves) leads to mid-gestation embryonic
lethality (Yao et al., 1998). Embryos suffer from neural tube defects
and aberrant cell proliferation (Yao et al., 1998); surprisingly, this sug-
gests that H3K27ac is not required for establishing the transcriptional
programming during early lineage speciﬁcation. This is consistent with
the ﬁnding that the effect of histone acetylation on chromatin access-
ibility is rather subtle (Wang et al., 2000). Therefore, H3K27ac may
act synergistically to increase chromatin accessibility at active regula-
tory elements, but likely is not sufﬁcient to activate a locus.
Together these studies suggest that several epigenetic marks, in
particular H3K27me3 and H3K4me3, are required for lineage speciﬁ-
cation, but for the most part it appears that epigenetic modiﬁcations
may reinforce lineage commitment rather than direct it. As new sin-
gle/low-cell molecular approaches are implemented to evaluate gene
regulation and epigenetic patterning through this important develop-
mental window, new insights into the molecular hierarchy of gene
regulation may be revealed.
Dynamics of genomic imprinting during
embryonic development
As discussed above, a subset of genomic loci maintain gamete DNA
methylation throughout epigenetic reprogramming in the embryo.
These domains are termed germline differentially methylated regions
(gDMRs) and their mono-allelic parent-of-origin DNA methylation per-
sists through cell differentiation and into adulthood. GDMRs can regu-
late nearby genes, resulting in mono-allelic gene expression, termed
genomic imprinting. In mice, there are 23 maternal and three paternal
gDMRs regulating the gene expression of ~151 genes (https://www.
mousebook.org/imprinting-gene-list). Collectively, imprinted genes are
essential for development, as demonstrated by embryo manipulation
experiments used to generate embryos with exclusively maternal or
paternal genomes (McGrath and Solter, 1984; Surani et al., 1984).
These embryos showed severe developmental and placental defects
and do not survive.
There has been extensive investigation into the mechanisms allow-
ing gDMRs to evade the DNA methylation erasure in the pre-
implantation embryo. Several essential proteins have been identiﬁed,
including DNA-binding proteins (ZFP57, UHRF1), key interactors
(TRIM28/KAP1) and histone binding proteins (PGC7/Stella) (Bostick
et al., 2007; Sharif et al., 2007; Li et al., 2008; Quenneville et al., 2011;
Messerschmidt et al., 2012; Nakamura et al., 2012). These appear
to assemble in a complex that facilitates recruitment of DNMT1
and the H3K9 methyltransferase SETDB1 and exclusion of DNA
demethylation enzymes (TETs) at imprinted gDMRs (Messerschmidt,
2012).
A recent study has also shown that genomic imprinting can be con-
ferred by another epigenetic mark in addition to DNA methylation:
maternal H3K27me3 inherited from the oocyte (Inoue et al., 2017a).
Inoue and colleagues (2017a) identiﬁed several domains where the
maternal allele was silenced by H3K27me3, thereby mediating
paternal-speciﬁc gene expression. Intriguingly, this non-canonical form
of imprinting was only able to be maintained in extra-embryonic
lineages post-implantation (Inoue et al., 2017a), suggesting embryonic
lineages effectively reprogram the parental bias at these domains.
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Human development: how
conserved are mechanisms
between mouse and human?
Using low-input and single-cell sequencing techniques, the ﬁrst
advances with human samples were made in recent years, allowing us
to compare the transcriptome, methylome and chromatin accessibil-
ity of human gametes and early embryos with what is known from
mouse models. Other technologies, such as Hi-C, are likely to follow
soon, but current ChIP-seq methods still require at least one hundred
cells, making progress with human oocytes and early cleavage stage
embryos more challenging. So far, studies on human development
have shown that, in general, DNA methylation patterns and repro-
gramming events are relatively conserved between mouse and human
(Table II). This supports the mouse as a model organism for elucidat-
ing general mechanisms of epigenetic reprogramming in early devel-
opment. However, when looking in detail, differences can be
observed, likely with functional consequences (Table II). In the fol-
lowing sections, we highlight the known differences between human
and mouse.
Gametes
Similar to mice, human PGCs undergo almost complete erasure of
DNA methylation during early embryonic development (Guo et al.,
2015, 2017b; Gkountela et al., 2015). Given the difﬁculties in obtain-
ing samples from late gestation foetal gonads and immature gametes,
the resetting of DNA methylation during spermatogenesis and
oogenesis remains unexplored. However, the DNA methylome of
human mature gametes, gives us some insights into epigenetic pro-
gramming events during gametogenesis.
There are substantial physiological differences between mammalian
species during spermatogenesis (Ehmcke et al., 2006), and yet, global
epigenetic trends in mature sperm, such as DNA hyper-methylation
in inter-genic regions and the histone-to-protamine exchange, are
similar (Molaro et al., 2011). However, some aspects of the de-novo
DNA methylation mechanisms may differ between mouse and
human. Recently, a novel DNA methyltransferase (DNMT3C) was
discovered, speciﬁcally active at young transposable elements during
mouse spermatogenesis (Barau et al., 2016). In male mice, this
enzyme is crucial for fertility, but this gene is not present in the
human genome. Furthermore, while DNMT3L is essential for sperm-
atogenesis in mice (Bourc’his et al., 2001), DNMT3L appears to not
be expressed at any time during human spermatogenesis (Marques
et al., 2011). While the replacement of histones by protamines is
conserved, ~10-fold more nucleosomes appear to be retained in
human sperm than in mouse sperm (Hammoud et al., 2009;
Brykczynska et al., 2010). Retained histones may therefore be more
likely to permit paternal epigenetic regulation of transcription in the
pre-implantation embryo (Carrell, 2012; Miller et al., 2010), although
this remains to be shown.
The ﬁrst study to report DNA methylation patterns in human
oocytes used RRBS, which mainly captures CpG islands and other
CG-rich sequence and covers 5–10% of the genome (Guo et al.,
2014). Since then, a genome-wide approach on pools of oocytes and
two single-cell studies have been published, all together giving us a
very comprehensive understanding of the human fully grown oocyte
methylome (Okae et al., 2014; Yu et al., 2017; Zhu et al., 2018).
Human oocytes have a higher average DNA methylation level than
mice (~54% in humans versus ~40% in mice) (Data source: PRJDB18
and PRJDB4030) (Kobayashi et al., 2012; Okae et al., 2014) (Fig. 4A).
Despite the increase in fully methylated regions in human oocytes, it
is still predominantly restricted to gene bodies (Fig. 4B). Indeed, a lar-
ger proportion of genes are methylated in human oocytes than in
mouse (Fig. 4C); however, this is likely not due to an overall increase
in transcription in human oocytes, as a similar number of transcripts
were detected (FPKM>1) (Data source: GSE44183) (Xue et al.,
2013). These ﬁndings suggest either that DNMTs may be more active
in human oocytes or that the relatively longer duration of oocyte
maturation in humans compared to mouse (~150 days vs. 21 days,
respectively) permits more extensive accumulation of DNA methyla-
tion (Gougeon, 1986; Hiura et al., 2006). Notably, DNMT3L, a co-
factor of DNMT3A that is essential for de-novo methylation in mouse
oocytes (Bourc’his et al., 2001; Smallwood et al., 2011; Shirane et al.,
2013), is not expressed in human oocytes (Guo et al., 2014; Okae
et al., 2014). It is currently unknown if DNMT3A can function inde-
pendently in the human oocyte or if it is supported by other factors,
like DNMT3B.
From germ cells to the embryo
After fertilisation, there is global reprogramming of DNA methyla-
tion in the human pre-implantation embryo with lowest levels
attained at the blastocyst stage (Guo et al., 2014; Okae et al., 2014;
Smith et al., 2014; Zhu et al., 2018). The paternal genome is actively
demethylated ﬁrst and more substantially, whereas the maternal
genome shows maintenance of much of the oocyte-derived methy-
lation (Guo et al., 2014; Okae et al., 2014; Zhu et al., 2018). The
retention of maternal methylation is considerably more substantial
in the human than in the mouse, suggesting there is less passive
demethylation and that perhaps DNMT1 has a more active role in
the human pre-implantation embryo (Fig. 4A and B). As discussed in
the section above, in mice, gDMRs are protected from passive
demethylation by a complex including ZFP57 (Messerschmidt,
2012). Interestingly, unlike mice, ZFP57 is not expressed in human
oocytes (Okae et al., 2014), but is still required for maintenance of
imprinting during human development (Mackay et al., 2008). Thus
ZFP57 is required for maintaining imprinted gDMRs in both mouse
and human, but the developmental stage for its requirement differs.
A profound difference between human and mouse during early
pre-implantation development is the discrepancy in timing of ZGA.
Whereas the mouse genome undergoes the major wave of ZGA at
the 2-cell stage, in human embryos this occurs at the 8-cell stage
(Braude et al., 1988; Aoki et al., 1997). Despite these differences in
timing, a recent study has shown that pre-ZGA embryos have wide-
spread open chromatin in both mouse and human, and this unusual
chromatin landscape is rapidly remodelled upon ZGA (Wu et al.,
2018). Importantly, using an inhibitor of transcription (α-amanitin) in
mouse and human embryos, they were able to show that this trans-
ition of chromatin accessibility was in fact dependent on transcrip-
tional activation (Wu et al., 2018). The widespread open chromatin
pattern in transcriptionally silent mouse zygotes has been shown to
be linked to non-canonical patterning of H3K4me3 in the oocyte
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Table II Comparative evaluation of epigenetic features and processes evaluated during human and mouse
development to date.
Tissue/cell
type
Epigenetic
feature/process
Mouse Human Reference Relative
similarity
PGCs DNA methylation
erasure
Global DNA methylation and
imprinted DMRs are erased
upon PGC speciﬁcation
Global DNA methylation and imprinted
DMRs are erased upon PGC
speciﬁcation
Guibert et al. (2012),
Seisenberger et al. (2012),
Guo et al. (2015),
Gkountela et al. (2015),
Guo et al. (2017b)
Sperm DNA methylation
patterns in sperm
~80% genome-wide
methylation, with unmethylated
regulatory domains
~75% genome-wide methylation, with
unmethylated regulatory domains
Oakes et al. (2007),
Kobayashi et al. (2012),
Guo et al. (2014)
De novo DNMTs in
spermatogenesis
DNMT3A, 3L and 3C are
essential for spermatogenesis
Unknown; DNMT3A, 3B and 1 are
dynamically expressed during
spermatogenesis, but there is no
expression of DNMT3L and no
orthologous gene for DNMT3C
Bourc’his et al. (2001),
Kaneda et al. (2004),
Barau et al. (2016),
Marques et al. (2011)
Retention of
modiﬁed histones
in sperm
~1% genome-wide, enriched at
developmental promoters
~10% genome-wide, enriched at
developmental promoters
Brykczynska et al. (2010),
Hammoud et al. (2009)
Oocyte DNA methylation
patterns in the
oocyte
~40% genome-wide
methylation and localised
predominantly to expressed
gene bodies
~54% genome-wide methylation and
localised predominantly to gene bodies
Okae et al. (2014),
Kobayashi et al. (2012)
De novo DNMTs in
oogenesis
DNMT3A and 3L are essential
for establishing DNA
methylation in oocytes
Unknown; in human oocytes, DNMT1,
3A and 3B are expressed, but not
DNMT3L
Bourc’his et al. (2001),
Smallwood et al. (2011),
Shirane et al. (2013),
Guo et al. (2014),
Okae et al. (2014)
Histone
modiﬁcation
patterns
Non-canonical distributions of
both H3K4me3 and
H3K27me3 across regions
lacking DNA methylation
Unknown Zhang et al. (2016), Dahl
et al. (2016), Hanna et al.
(2018), Zheng et al. (2016)
Higher order
chromatin
organisation
Weak TADs and loops and a
loss of A/B compartments
upon transcriptional silencing
Unknown Flyamer et al. (2017), Du
et al. (2017), Ke et al. (2017)
Pre-
implantation
embryo
DNA methylation
dynamics in pre-
implantation
development
Active loss of paternal
methylation and passive loss of
maternal methylation; regions
of DNA methylation turnover
Active loss of paternal methylation and
minimal passive loss of maternal
methylation; regions of DNA
methylation turnover
Guo et al. (2014), Okae et al.
(2014), Smith et al. (2014),
Zhu et al. (2018)
ZFP57-mediated
protection of
imprinted DMRs
Maternal/oocyte contribution
of ZFP57 is required to protect
imprints in pre-implantation
development
ZFP57 is required to protect imprints,
but it is not expressed in human
oocytes; expression is initiated in the
pre-implantation embryo
Quenneville et al. (2011), Li
et al. (2008), Okae et al.
(2014), Mackay et al. (2008),
Sanchez-Delgado et al.
(2016b)
Chromatin
conﬁguration post-
fertilisation
Widespread open chromatin
that resolves upon ZGA
Widespread open chromatin that
resolves upon ZGA
Wu et al. (2016), Wu et al.
(2018)
Histone
modiﬁcation
dynamics
Non-canonical maternal
H3K4me3 resolves to canonical
pattern, while maternal
H3K27me3 is predominantly
erased
Unknown Zheng et al. (2016), Zhang
et al. (2016), Dahl et al.
(2016)
Higher order
chromatin
organisation
Canonical patterns of TADs,
loops, and A/B compartments
restored during early
embryogenesis
Unknown Flyamer et al. (2017), Ke et al.
(2017), Du et al. (2017)
Continued
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Table II Continued
Tissue/cell
type
Epigenetic
feature/process
Mouse Human Reference Relative
similarity
Blastocyst DNA methylation
patterns in
blastocyst-stage
embryos
Maintenance of imprinted
DMRs and low levels of oocyte
methylation patterns
Maintenance of imprinted DMRs and
persistent oocyte methylation patterns
Kobayashi et al. (2012), Okae
et al. (2014), Guo et al.
(2014), Zhu et al. (2018)
Post-
implantation
embryonic
tissues
Number of
imprinted genes
~125–151, with numerous
imprinted gene clusters
~50–90, with numerous imprinted gene
clusters
Crowley et al. (2015), Babak
et al. (2015), Sanchez-
Delgado et al. (2016a),
Santoni et al. (2017),
Andergassen et al. (2017)
Epigenetic
regulation of
imprinted gene
clusters
Non-coding RNAs and
differential DNA methylation
regulate imprinted gene
expression
Non-coding RNAs and differential DNA
methylation regulate imprinted gene
expression
Reviewed in Reik and Walter
(2001)
X chromosome
inactivation (XCI)
in embryogenesis
Random XCI, mediated by
opposing expression of Xist and
Tsix
Random XCI, mediated by expression of
XIST from the inactive X
Reviewed in Furlan and
Rougeulle (2016)
Genetic
polymorphisms
inﬂuence imprinted
gene expression
Cis-acting strain-speciﬁc SNPs
can inﬂuence allelic bias in
imprinted gene expression
Cis-acting SNPs can inﬂuence allelic bias
in imprinted gene expression
Crowley et al. (2015),
Andergassen et al. (2017),
Babak et al. (2015), Garg
et al. (2012)
Tissue-speciﬁc
imprinted gene
expression
Several imprinted genes are
tissue-speciﬁc
Several imprinted genes are tissue-
speciﬁc
Crowley et al. (2015),
Andergassen et al. (2017),
Babak et al. (2015)
Post-
implantation
extra-
embryonic
tissues
Genome-wide
methylation
patterns
Extra-embryonic tissues are
characterised by large partially
methylated domains
Extra-embryonic tissues are
characterised by large partially
methylated domains
Rossant et al. (1986),
Schroeder et al. (2013),
Decato et al. (2017)
XCI in extra-
embryonic tissues
Imprinted inactivation of the
paternal X chromosome,
conferred by repression of
maternal Xist by oocyte-
derived H3K27me3
Random XCI Takagi and Sasaki (1975),
Migeon and Do (1979),
Penaherrera et al. (2003),
Inoue et al. (2017b)
Abundance of
placental-speciﬁc
imprinted gDMRs
None reported >1500 placental-speciﬁc gDMRs
reported
Hanna et al. (2016), Hamada
et al. (2016), Sanchez-
Delgado et al. (2016a)
Polymorphic
imprinted DMRs
Unknown Pervasive in extra-embryonic tissues Hanna et al. (2016), Sanchez-
Delgado et al. (2016a)
Non-canonical
imprinting
Several non-canonical placenta-
speciﬁc imprinted genes
mediated by maternal
H3K27me3
Unknown Inoue et al. (2017a)
Large placenta-
speciﬁc imprinted
domains: KvDMR
Distal placental-speciﬁc
imprinting of genes in the
KvDMR locus
While the canonical imprinting at
KvDMR is conserved, distal genes are
not imprinted in placenta
Lewis et al. (2004); Frost
et al. (2010)
Large placenta-
speciﬁc imprinted
domains:
Chromsome 19
micro-RNA cluster
No orthologous region Chromosome 19 micro-RNA cluster is
imprinted speciﬁcally in placenta
Noguer-Dance et al. (2010)
Colour key: green – highly similar; yellow – similar, but with key differences identiﬁed; red – highly discrepant; grey – unknown in mouse or human.
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(Dahl et al., 2016; Ancelin et al., 2016; Zhang et al., 2016), and while
ChIP-seq data is currently unavailable for human embryos, one can
speculate that similar mechanisms may be involved.
In pre-implantation development, there are notable differences in
the transcriptome of mouse and human embryos (Xue et al., 2013;
Yan et al., 2013; Blakeley et al., 2015). Although similar transcription
factors appear to function in mouse and human pre-implantation
embryos, the temporal regulation and the transcriptional networks
they regulate can differ, suggesting there are divergent aspects of
early development (Blakeley et al., 2015; Fogarty et al., 2017; Wu
et al., 2018). It is not clear yet if the epigenome may be instructive
for some of these transcriptional differences. However, one study
found that there was an increasing correlation between transcription
and promoter methylation from the zygotic stage to post-
implantation, especially after ZGA, in the human embryo (Guo et al.,
2014). This suggests that the retention of maternal DNA methylation
in the human embryo may play a role.
Initially, pre-implantation development was thought to be exclu-
sively a time of DNA methylation erasure (Smith et al., 2012); how-
ever, recent studies in mouse and human show that there is de-novo
methylation during pre-implantation development (Amouroux et al.,
2016; Zhu et al., 2018). Thus far, this phenomenon has been best
described in human development. Zhu and colleagues found two
phases of de-novo methylation: ﬁrst, the paternal genome in the zyg-
ote between the early- to mid-pronuclear stage, just after a major
wave of active demethylation; second, between the 4- and 8-cell
stage coinciding with ZGA. Regions gaining methylation are enriched
in repetitive elements, especially evolutionary younger classes of
SINEs and LINEs. The targeting of de-novo methylation to potentially
more active repeat elements has been suggested to repress their
transcriptional activity to avoid mobilisation and safeguard genome
stability during ZGA (Smith et al., 2014). However, methylation of
these regions was surprisingly transient, as they became demethy-
lated again in the following developmental stages (Zhu et al., 2018).
These ﬁndings highlight the unexpectedly complex methylation
dynamics in the early embryo.
Post-implantation development
The epigenetic regulation of lineage speciﬁcation in the post-
implantation embryo is largely unexplored in humans due to chal-
lenges in obtaining samples. Our current knowledge of epigenetics in
post-implantation development is largely extrapolated from human
embryonic stem cell differentiation systems, which have provided
important insights into tissue differentiation, as discussed elsewhere
(Xie et al., 2013). However, recent advances of in-vitro culture of
human embryos have enlivened the ethical discussion about embryo
culture past the implantation-stage blastocyst (Weimar et al., 2013;
Shahbazi et al., 2016), and may eventually allow the study of epigen-
etics in post-implantation development in vivo.
Genomic imprinting
The majority of imprinted gene clusters identiﬁed in mouse are con-
served in their methylation status, allelic expression and synteny in
Figure 4 Comparison of DNA methylation in human and mouse development. (A) Beanplots showing the distribution of DNA methylation per-
centages of 100-CpG running windows (minimum coverage of 10 CpGs) in human (top) and mouse (bottom) GV oocytes, sperm and blastocysts,
with human oocytes and blastocysts being notably more methylated than mouse oocytes and blastocysts, respectively. (B) Screenshot of DNA
methylation at the KvDMR imprinted locus in human (top) and mouse (bottom) GV oocytes, sperm and blastocysts. The locus illustrates the
increased number of regions that are fully methylated in human compared to mouse oocytes. Additionally, the human blastocyst retains the maternal
pattern of methylation more substantially than the mouse blastocyst. (C) Proportion of orthologous genes that are methylated in human and mouse
oocytes. Orthologous genes were deﬁned by ENSEMBL BioMart and categorised as highly expressed (FPKM>10), intermediately expressed
(1<FPKM<10) or lowly expressed (FPKM<1). These genes were then evaluated for overlap with fully methylated (>75%) and intermediately methy-
lated (25–75%) 100-CpG windows; genes that did not overlap a methylated window were deﬁned as unmethylated. This analysis demonstrates that
the increase in methylated domains in human oocytes reﬂects an increased number of genes becoming fully methylated compared to mouse.
Publically available data was used for these analyses, including RNA-seq data for mouse and human oocytes (GSE44183) (Xue et al., 2013) and
DNA methylation data from mouse (Kobayashi et al., 2012) and human (Okae et al., 2014) oocytes, sperm and blastocyst embryos.
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humans, although with several notable exceptions (Reik and Walter,
2001). There has been considerable work identifying novel imprinted
genes in humans, using a combination of sequencing approaches over
single nucleotide polymorphisms (SNPs) (Metsalu et al., 2014; Babak
et al., 2015; Hamada et al., 2016; Santoni et al., 2017) or cases with
genomic imbalances (Choufani et al., 2011; Yuen et al., 2011;
Kobayashi et al., 2012; Court et al., 2014; Hanna et al., 2016;
Sanchez-Delgado et al., 2016). These studies have estimated there
are 50–90 imprinted genes in humans; however, many more DMRs
have been identiﬁed, but whether these are all regulating gene
expression remains unclear. The task of identifying an exhaustive list
of imprinted loci in healthy tissues has proven challenging, due to the
limited frequency and availability of parental information for SNPs in
human populations (Metsalu et al., 2014; Hamada et al., 2016;
Santoni et al., 2017), and the pervasive tissue-speciﬁc and poly-
morphic imprinting (Babak et al., 2015; Hanna et al., 2016). Overall,
ﬁndings suggest that imprinted gene expression and methylation may
be more widespread and variable in humans than in mice; however,
as similar screens are now being implemented in mice (Babak et al.,
2015; Crowley et al., 2015; Andergassen et al., 2017), comparable
patterns may emerge.
As discussed in section above, the genome-wide methylation pro-
ﬁles in human and mouse gametes are remarkably similar. This is not-
able considering that the repertoire of DNMTs responsible for these
patterns are not identical. In the foetus and adult, human imprinted
genes are similarly regulated by gDMRs that are maintained through
early development, yet to date very little is known about how
imprints are protected during human reprogramming. Foremost, the
maintenance of imprinted gDMRs in the human pre-ZGA embryo
appears to be independent of ZFP57 (Okae et al., 2014). However,
mutations in ZFP57 cause 50% of cases with transient neonatal dia-
betes with loss of imprinting at multiple loci, termed a multilocus
imprinting disorder (MLID) (Sanchez-Delgado et al., 2016b), support-
ing that ZFP57 is required during later stages. Several research groups
have sought to identify genetic mutations associated with MLID to
identify novel regulators in imprinting in humans; surprisingly, very
few genes have been identiﬁed (Sanchez-Delgado et al., 2016b). In
addition to ZFP57, maternal effect genes NLRP5, KHDC3L and
primate-speciﬁc NLRP7 are associated with loss of imprinting
(Murdoch et al., 2006; Parry et al., 2011; Docherty et al., 2015).
However, these encode cytoplasmic proteins and are thought to be
components of the subcortical maternal complex. Therefore, they
may be involved in controlling the intracellular localisation of epigen-
etic regulators in the oocyte or zygote, rather than having a direct
role in imprinting (Monk et al., 2017). Together, these ﬁndings sug-
gest that the protection of DNA methylation at imprinted gDMRs is
required in both mouse and human, but at least some of the epigen-
etic modiﬁers may have evolved distinct roles between species.
Recent studies have shown that imprinted gDMRs are far more
pervasive in the human placenta than in foetal and adult tissues
(Hamada et al., 2016; Hanna et al., 2016; Sanchez-Delgado et al.,
2016a). The number of placental-speciﬁc imprinted gDMRs is
reported to be upwards of 1500, and intriguingly all of these appear
to inherit methylation from the oocyte (Hamada et al., 2016). The
role of these placental-speciﬁc DMRs is still under debate, as many
are not associated with genes expressed in the placenta. These
domains may therefore be recently evolved imprinted sites (Hanna
and Kelsey, 2014), as the vast majority are not conserved between
mouse and human (Smith et al., 2014; Hanna et al., 2016). In mouse,
placental-speciﬁc imprinting appears to be largely conferred by non-
canonical repression by maternal H3K27me3 (Lewis et al., 2006;
Inoue et al., 2017a), and yet, to date, it is unknown whether humans
have this form of non-canonical imprinting.
Wider implications for human
disease and fertility
Recent advances have allowed us to gain the ﬁrst insights into epigen-
etic regulation of development, which will be essential in furthering
our understanding of the role of epigenetics in human infertility,
maternal and foetal health, and complications of pregnancy. As this
ﬁeld develops, it will also become clear whether epigenetic patterns
established during prenatal development may inﬂuence the lifelong
health of offspring and, additionally, whether early epigenetic repro-
gramming events are susceptible to perturbation by environmental
exposures (toxins), physiological factors (stress, diet), or medical
interventions (assisted reproductive technologies, ART). In this sec-
tion, we will provide an overview of the recent developments and
future directions in these areas of research.
Infertility
Evidence from association studies support that aberrant epigenetic
programming in sperm may contribute to male infertility. Several
studies have found an association between increased histone reten-
tion and low sperm count or infertility (Aoki et al., 2005; Torregrosa
et al., 2006; Garcia-Peiro et al., 2011; Hammoud et al., 2011;
Denomme et al., 2017). Additionally, aberrant sperm DNA methyla-
tion patterns has also been associated with semen parameters and
male infertility (Montjean et al., 2015; Urdinguio et al., 2015).
Furthermore, sequence variants in DNMT3B and DNMT1 have been
associated with male infertility (Tang et al., 2017) and variants in
DNMT3L have been associated with abnormal sperm methylation
(Kobayashi et al., 2009).
The role of epigenetics in female infertility has not been evaluated
directly due to the invasive procedures required for obtaining oocytes
from women. However, there are examples of mutations or genetic
anomalies that demonstrate the necessity of oocyte methylation in
obtaining a healthy pregnancy (Tomizawa and Sasaki, 2012). Women
homozygous for mutations in NLRP7, NLRP5 or KHDC3L have preg-
nancies with a loss of all or some maternal imprints, resulting in
recurrent biparental hydatidiform molar pregnancies that miscarry
early in development (Murdoch et al., 2006; Parry et al., 2011;
Docherty et al., 2015). Furthermore, cases of complete hydatidiform
molar pregnancies, in which there is only a paternal genetic contribu-
tion, result in no embryo and abnormal placental development (Kajii
and Ohama, 1977). Finally, unexplained miscarriage has been asso-
ciated with defects in imprinted DNA methylation in foetal or placen-
tal samples (Hanna et al., 2013; Pliushch et al., 2010; Zheng et al.,
2013), which may be a failure to establish imprints or to maintain
them. Together, these ﬁndings support that gametic epigenetic
defects contribute to human infertility and early pregnancy loss;
569Epigenetics in development
however, the extent to which these changes may be causal in unex-
plained infertility or subfertility remains unclear.
Pregnancy complications
Imprinting syndromes are extensively studied developmental epigen-
etic disorders (Peters, 2014). Loss of allele-speciﬁc gene expression
at speciﬁc imprinted loci can result in developmental defects of vary-
ing severity, often involving aberrant foetal growth (reviewed else-
where; Ishida and Moore, 2013). The role of imprinted genes in
foetal growth and placentation (Bartolomei and Ferguson-Smith,
2011) has led to the suggestion that more subtle deregulation of
imprinting may contribute to pregnancy complications, such as pre-
eclampsia, and/or foetal growth restriction (Frost and Moore, 2010;
Moore et al., 2015). However, despite extensive study, many associa-
tions remain inconclusive (Koukoura et al., 2012).
The establishment or modulation of post-implantation tissue-spe-
ciﬁc epigenetic patterns, in particular DNA methylation, have also
been widely investigated for association with pregnancy complica-
tions. Studies have focused on placental biopsies because of the non-
invasive means of obtaining these samples from healthy and patho-
logical pregnancies, as well as the biological relevance (Januar et al.,
2015; Robinson and Price, 2015). While many DNA methylation
changes have been identiﬁed, studies have often been performed on
whole placental villi, which can obscure the interpretation of these
changes due to cell heterogeneity that may exist between patient
groups (Januar et al., 2015). Additionally, DNA methylation changes
may be a cause or a consequence of poor placental and/or foetal
development. Therefore, an optimised study design will be required
to determine whether epigenetic variation can predispose to adverse
pregnancy outcomes and, furthermore, whether these changes medi-
ate environmental inﬂuences.
Environmental and physiological inﬂuences
on epigenetic reprogramming events
The Developmental Origins of Health and Disease (DoHaD) hypoth-
esis posits that adaptive and maladaptive changes during foetal devel-
opment in response to environmental exposures can result in
predisposition to disease in adulthood (Wadhwa et al., 2009). A
well-known example of this is the severe prenatal caloric restriction
that took place during the Dutch famine, which resulted in increased
risk for obesity and comorbidities late in life (Roseboom et al., 2006).
It has been suggested that DoHaD effects could be mediated by epi-
genetic programming in response to these environmental cues.
Investigations into the effects of maternal diet, smoking and stress
on DNA methylation in offspring support this idea (Joubert et al.,
2012; Dominguez-Salas et al., 2014; Novakovic et al., 2014; Kupers
et al., 2015; Palma-Gudiel et al., 2015; Geraghty et al., 2016), while
other investigations, such as studies of maternal alcohol consumption,
have found no association (Sharp et al., 2018). A particularly compel-
ling example, is the evaluation of maternal diet on foetal DNA methy-
lation in Gambian rural communities. These populations experience
profound seasonal ﬂuctuations in nutrient and micro-nutrient avail-
ability, and it was found that maternal nutrient status was predictive
of DNA methylation patterns of so-called metastable epialleles (gen-
omic loci whose methylation varies between individuals in the
absence of genetic variants), including the imprinted gene VTRNA2-1
(Dominguez-Salas et al., 2014). A challenge for many studies is the
interpretation of observed methylation changes, as they are often
subtle differences and at only a few CpG sites. Therefore, comple-
mentary studies in mouse models are essential to evaluate whether
DNA methylation changes due to in-utero environmental exposures
can inﬂuence gene expression patterns and developmental progres-
sion (Waterland and Jirtle, 2003).
Additional evidence that early epigenetic programming is suscep-
tible to environmental factors comes from the study of pregnancy
outcomes associated with ART. With the increase in ART use glo-
bally, there has been an extensive effort to evaluate whether proce-
dures, such as ovarian stimulation, in-vitro fertilisation (IVF), intra-
cytoplasmic sperm injection (ICSI) and in-vitro culture, may increase
the risk of developmental epigenetic defects (Canovas et al., 2017).
ART procedures have been reproducibly associated with increased
risk of imprinting syndromes in human epidemiology studies, although
the prevalence is still extremely low (Hiura et al., 2014; White et al.,
2015). Studies directly evaluating epigenetic patterns in ART-
generated human embryos are scarce and since in-vivo samples as a
comparison group are inaccessible, results can be difﬁcult to inter-
pret. Nevertheless, targeted assessment of imprinted gDMRs in
human cultured embryos has shown that aberrant imprinting could
be present in >50% (White et al., 2015). It remains contentious
whether ART is associated with additional pregnancy complications
or long-term consequences for offspring health (Davies et al., 2012;
Hart and Norman, 2013; Liu et al., 2015; Fauser et al., 2014), and
whether these may be due to developmental epigenetic changes
remains to be explored.
Concluding remarks
The recent advances in low-input technologies has provided novel
insights into epigenetic dynamics during oogenesis and the earliest
events of embryonic development in mice. Studies to date have
revealed the unique epigenetic landscape of the oocyte, not only
DNA methylation, but also histone modiﬁcations and nuclear organ-
isation. Future work will continue to explore the underlying mechan-
isms and the functional importance of these non-canonical patterns.
The evaluation of epigenetic proﬁles in the early embryo suggest that
there is widespread erasure of gametic epigenetic patterns after fertil-
isation and subsequent re-establishment of DNA methylation, histone
modiﬁcations, chromatin accessibility and nuclear organisation. While
the mechanisms driving this reprogramming are unclear, it is apparent
that there are localised exceptions, including both canonical and non-
canonical imprinted regions.
At present, the study of epigenetic reprogramming events in
humans has been largely restricted to DNA methylation. In compari-
son to mice, there appear to be similar dynamics in both gametes
and the early embryo, and yet the proteins modulating these dynam-
ics are often divergent in timing or function. Thus, future investiga-
tions of epigenetic patterns in human development may not only
reveal further novel regulatory mechanisms, but also differences in
the extent of epigenetic information transmitted from gametes to
embryos. These discoveries will be essential in understanding the
inﬂuence of our environment on pregnancy and lifelong health of
offspring.
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